Categories: Health

an effective antiviral drug against HIV, limited by its high cost

He lenacapavirinnovator antiviral agent developed by Gilead, revolutionized prevention belonging HIV thanks to its impressive efficiency. With 100% protection for women and adolescents, this promises to be a game changer. However, their high pricewhich in the US can reach 38,900 euros, poses a serious challenge to global access.

Promising results in HIV prevention

Clinical study GOAL 1 revealed a remarkable efficacy of lenacapavir V HIV preventionespecially between women and teenage girls

in South Africa and Uganda. The antiviral drug prevented 100% of infections in the study group, sparking enthusiasm in the medical community as a major milestone in the fight against the devastating disease.

The findings, published in the New England Journal of Medicine and presented at the International AIDS Society congress in Munich, highlight lenacapavir’s potential as a revolutionary HIV prevention method. However, widespread adoption remains a challenge given the high cost of treatment.

Economic Issues and Global Access

El lenacapavir podría representar un cambio radical en la profilaxis del VIH si su precio se hace accesible globalmente.

He cost of medicine For many, it is prohibitively expensive, with a price of €20,221.50 for two injections in Spain. This financial barrier limits Universal access

especially in countries with fewer resourceswhere the need is acute but solvency is limited.

GileadThe manufacturer of lenacapavir has promised to develop global strategy improve access to treatment. While this initiative is welcome, there remains skepticism about whether these measures will be sufficient to address inequalities in access to this promising antiviral drug.

Comparison with current alternatives

A modern alternative to lenacapavir is prevention with tabletswhich has Monthly cost around 30 euros. This price difference makes the pills much more accessible to most people at risk of HIV infection.

Research shows that mass production lenacapavir could bring its cost down to around €40 per dose. Such a significant reduction would make lenacapavir a much more viable option compared to Current alternativeswhich has the potential to change the landscape of HIV prevention worldwide.

Source link

Admin

Share
Published by
Admin

Recent Posts

The product confirms rumors about the relationship between Amber Heard and Jason Momoa.

Sorted December 20, 2023, Aquaman and Royal Fart It is the most recent film in…

3 minutes ago

APEC 2024: This is the ‘Flying Palace’, the luxurious and huge plane in which the Sultan of Brunei reached Peru

The 'Flying Palace' is a Boeing 747-430, a widebody aircraft in which the Sultan of…

7 minutes ago

I’m a doctor and this is the perfect breakfast to strengthen your brain and keep you from gaining weight.

New research shows that protein-rich milk breakfast not only is it more filling than the…

9 minutes ago

LIGHT PRICE TODAY | The price of electricity this Wednesday jumped by 65%: hours of switching on household appliances are prohibitive

Tuesday, November 12, 2024, 8:17 p.m. Turning on household appliances on Wednesday, November 13th will…

15 minutes ago

What are WhatsApp drafts and what are they for?

WhatsApp is the most used messaging app in the world. The Meta-owned service has managed…

17 minutes ago

Dynamic Madrid will get rid of Virtus in the second half | Basketball | Sport

Real started in the third quarter, stepped up the game and got rid of Virtus…

20 minutes ago